UBS Group’s Insulet PODD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $93.6M | Buy |
445,939
+211,917
| +91% | +$53.3M | 0.01% | 1106 |
|
|
2025
Q4 | $66.5M | Buy |
234,022
+27,079
| +13% | +$8.47M | 0.01% | 1347 |
|
|
2025
Q3 | $63.9M | Buy |
206,943
+67,072
| +48% | +$21M | 0.01% | 1389 |
|
|
2025
Q2 | $43.9M | Sell |
139,871
-58,362
| -29% | -$16.8M | 0.01% | 1637 |
|
|
2025
Q1 | $52.1M | Buy |
198,233
+55,888
| +39% | +$15.1M | 0.01% | 1449 |
|
|
2024
Q4 | $37.2M | Buy |
142,345
+25,465
| +22% | +$6.41M | 0.01% | 1723 |
|
|
2024
Q3 | $27.2M | Buy |
116,880
+1,260
| +1% | +$259K | 0.01% | 1589 |
|
|
2024
Q2 | $23.3M | Buy |
115,620
+953
| +0.8% | +$172K | 0.01% | 1563 |
|
|
2024
Q1 | $19.7M | Buy |
114,667
+53,263
| +87% | +$9.93M | ﹤0.01% | 1702 |
|
|
2023
Q4 | $13.3M | Buy |
61,404
+535
| +0.9% | +$91.8K | ﹤0.01% | 1876 |
|
|
2023
Q3 | $9.71M | Buy |
60,869
+110
| +0.2% | +$24.6K | ﹤0.01% | 2006 |
|
|
2023
Q2 | $17.5M | Sell |
60,759
-18,555
| -23% | -$5.64M | 0.01% | 1541 |
|
|
2023
Q1 | $25.3M | Buy |
79,314
+58,230
| +276% | +$17.3M | 0.01% | 1214 |
|
|
2022
Q4 | $6.21M | Sell |
21,084
-17,757
| -46% | -$4.9M | ﹤0.01% | 2291 |
|
|
2022
Q3 | $8.91M | Buy |
38,841
+20,706
| +114% | +$5.19M | ﹤0.01% | 1890 |
|
|
2022
Q2 | $3.95M | Sell |
18,135
-1,065
| -6% | -$242K | ﹤0.01% | 2571 |
|
|
2022
Q1 | $5.12M | Sell |
19,200
-27,306
| -59% | -$6.7M | ﹤0.01% | 2515 |
|
|
2021
Q4 | $12.4M | Buy |
46,506
+16,088
| +53% | +$4.67M | ﹤0.01% | 1959 |
|
|
2021
Q3 | $8.65M | Sell |
30,418
-12,005
| -28% | -$3.42M | ﹤0.01% | 2157 |
|
|
2021
Q2 | $11.6M | Sell |
42,423
-14,056
| -25% | -$3.82M | ﹤0.01% | 1905 |
|
|
2021
Q1 | $14.7M | Sell |
56,479
-75,505
| -57% | -$20.2M | ﹤0.01% | 1645 |
|
|
2020
Q4 | $33.7M | Buy |
131,984
+87,363
| +196% | +$21.7M | 0.01% | 1016 |
|
|
2020
Q3 | $10.6M | Sell |
44,621
-7,567
| -14% | -$1.59M | ﹤0.01% | 1603 |
|
|
2020
Q2 | $10.1M | Buy |
52,188
+16,935
| +48% | +$3.24M | ﹤0.01% | 1490 |
|
|
2020
Q1 | $5.84M | Sell |
35,253
-1,076
| -3% | -$197K | ﹤0.01% | 1799 |
|
|
2019
Q4 | $6.22M | Sell |
36,329
-10,889
| -23% | -$1.81M | ﹤0.01% | 2403 |
|
|
2019
Q3 | $7.79M | Buy |
47,218
+13,392
| +40% | +$1.88M | ﹤0.01% | 1965 |
|
|
2019
Q2 | $4.04M | Sell |
33,826
-524
| -2% | -$53.7K | ﹤0.01% | 2508 |
|
|
2019
Q1 | $3.27M | Buy |
34,350
+10,436
| +44% | +$894K | ﹤0.01% | 2558 |
|
|
2018
Q4 | $1.9M | Buy |
23,914
+15,384
| +180% | +$1.3M | ﹤0.01% | 3085 |
|
|
2018
Q3 | $904K | Buy |
8,530
+1,000
| +13% | +$93.6K | ﹤0.01% | 3937 |
|
|
2018
Q2 | $646K | Sell |
7,530
-3,157
| -30% | -$283K | ﹤0.01% | 4126 |
|
|
2018
Q1 | $926K | Buy |
10,687
+7,063
| +195% | +$549K | ﹤0.01% | 3772 |
|
|
2017
Q4 | $250K | Buy |
3,624
+25
| +0.7% | +$1.64K | ﹤0.01% | 4763 |
|
|
2017
Q3 | $199K | Buy |
3,599
+1,009
| +39% | +$55.1K | ﹤0.01% | 4851 |
|
|
2017
Q2 | $133K | Buy |
2,590
+1,414
| +120% | +$61.4K | ﹤0.01% | 5007 |
|
|
2017
Q1 | $51K | Buy |
1,176
+874
| +289% | +$37.5K | ﹤0.01% | 5515 |
|
|
2016
Q4 | $12K | Sell |
302
-1,698
| -85% | -$63.3K | ﹤0.01% | 6818 |
|
|
2016
Q3 | $82K | Sell |
2,000
-1,109
| -36% | -$43.8K | ﹤0.01% | 5118 |
|
|
2016
Q2 | $94K | Buy |
3,109
+9
| +0.3% | +$280 | ﹤0.01% | 5067 |
|
|
2016
Q1 | $102K | Hold |
3,100
| – | – | ﹤0.01% | 4970 |
|
|
2015
Q4 | $118K | Buy |
3,100
+1,000
| +48% | +$33.7K | ﹤0.01% | 5082 |
|
|
2015
Q3 | $55K | Buy |
2,100
+1,000
| +91% | +$30.3K | ﹤0.01% | 5758 |
|
|
2015
Q2 | $34K | Hold |
1,100
| – | – | ﹤0.01% | 6367 |
|
|
2015
Q1 | $37K | Buy |
1,100
+831
| +309% | +$28.1K | ﹤0.01% | 6331 |
|
|
2014
Q4 | $12K | Buy |
+269
| New | +$11.5K | ﹤0.01% | 8233 |
|
Other funds holding PODD
VCM
VPM
UBS Group's PODD Position: Q1 2026 in Review
UBS Group increased its Insulet (PODD) stake by 91% in Q1 2026, buying an estimated $53.3M and bringing the position to 445,939 shares worth $93.6M. The position accounts for 0.01% of the portfolio, ranked #1106.
UBS Group first reported a position in PODD in Q4 2014 and has held it in 46 quarters since. 785 funds tracked by Wall St. Rank hold PODD as of Q1 2026.
- UBS Group held 445,939 shares of Insulet worth $93.6M as of Q1 2026.
- UBS Group bought 211,917 Insulet shares in Q1 2026, an estimated $53.3M.
- Insulet made up 0.01% of UBS Group's portfolio in Q1 2026, its #1106 holding.
- UBS Group first reported a position in Insulet in Q4 2014 and has held it in 46 quarters since.
- 785 funds tracked by Wall St. Rank held Insulet as of Q1 2026.
Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.